Surge Therapeutics
Clinical trials sponsored by Surge Therapeutics, explained in plain language.
-
New drug injected during bladder surgery aims to stop cancer's return
Disease control Recruiting nowThis early-stage trial tests a new drug called STM-416 that is given directly into the bladder during surgery to remove recurrent high-grade papillary bladder tumors. The study involves 75 adults with a history of this cancer who are at high risk for recurrence. The main goals ar…
Phase: PHASE1, PHASE2 • Sponsor: SURGE Therapeutics • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New drug during prostate surgery aims to boost cancer fight
Disease control Recruiting nowThis early-stage trial tests a new drug called STM-416p, given directly into the prostate area during surgery to remove the prostate in men with prostate cancer. The main goal is to check the drug's safety and find the best dose. About 18 men with intermediate to high-risk prosta…
Phase: PHASE1 • Sponsor: SURGE Therapeutics • Aim: Disease control
Last updated May 19, 2026 11:47 UTC